No products in the cart.
AGE-Reader mu
Fast, non-invasive, and comfortable assessment of AGEs by measuring skin autofluorescence.
Description
The AGE Reader offers a non-invasive, elegantly simple, and fast determination of AGEs
(Advanced Glycation Endproducts) by measuring
skin autofluorescence (Skin AF). Thanks to the excellent scientific basis in the literature,
the method is ideal for screening in healthcare,
medical practices, clinics, occupational health management (OHM),
epidemiology, and other fields.
What is measured?
The AGE Reader determines so-called Advanced Glycation Endproducts (AGEs), metabolic end products accumulated throughout the body. These appear in larger quantities in at-risk individuals as a result of oxidative stress, in the case of incipient or existing metabolic disorders, or an inadequate lifestyle. AGEs accelerate cellular aging and lead to deposits in the blood vessels. Overall, AGEs play a vital role in the development of chronic diseases such as diabetes, cardiovascular conditions, and kidney disease.
Additional basic information about AGEs can be found here.
How is it measured?
The measurement is performed using an optical method on the skin of the forearm, which is briefly placed on the AGE Reader. The result is displayed within seconds on the integrated color screen, compared to the reference value of a person of the same age, and categorized into a risk level. The portable AGE Reader, equipped with a lithium-ion battery, can be easily used in different locations without additional effort. Values can be transmitted via Bluetooth® to a PC for convenient management in the AGE Reader application. No consumables are required.
What does the measurement mean for the services you offer?
With the AGE Reader application (Windows and Mac), you can create an impressively presented yet easy-to-understand risk report based on the measured value, which you can provide to your client. Thus, you can clearly document risks and progress and show the client the directly measurable benefits of planned or performed interventions.
Why measure AGEs?
The method has been validated in recent years in various large-scale clinical studies involving tens of thousands of individuals from healthy control groups, as well as patients with diabetes, cardiovascular, and kidney diseases. The AGE Reader has been used for numerous publications on Advanced Glycation Endproducts, their effects, and their clinical relevance. One of the most important studies in recent years presents the results of a population study with nearly 72,000 participants from a wide age spectrum. The authors conclude:
“Non-invasive determination of skin autofluorescence [AGE Reader] can be used in the general population to estimate the risk of type 2 diabetes mellitus, cardiovascular disease, or mortality.”
Additionally, the measurement method is extremely elegant. The AGE Reader examination is:
fast – approximately 10 seconds
comfortable for the patient – the forearm is placed on the device
non-invasive – optical measurement at the skin level
completely operator-independent – requires no specialized medical personnel
cost-effective – no consumables
Screening with the AGE Reader has particular clinical value for detection and risk assessment, independent of hyperglycemia or metabolic syndrome.
Finally, you benefit from an advantageous reimbursement possibility and rapid amortization. We are happy to inform you: +49 6333 9909030.